Abstract: A process for treating human skin by inhibiting serine protease formation involving contacting the skin with a composition containing a sterol sulfate.

Abstract: A hypocholesterolemic composition containing: (a) an active ingredient selected from the group consisting of a phytostenol, a phytostenol ester, and mixtures thereof; and (b) a potentiating agent selected from the group consisting of a chitosan, a phytostenol sulfate, a (deoxy)ribonucleic acid, and mixtures thereof.

Abstract: A hair cosmetic formulation containing a cationic bipolymer and a polyvinylpyrrolidone/viny acetate copolymer in a weight ratio from 1:10 to 1:50.

Abstract: A process of producing a coated tocopheryl succinate is provided. The process comprises contacting a tocopheryl succinate powder with a solution of a pharmaceutically acceptable binder, said tocopheryl succinate being maintained in a fluidized bed during said contacting by passage of a fluidizing gas through said bed. The solvent is then evaporated from said contacted tocopheryl succinate in said fluidized bed. The temperature of said fluidizing gas when introduced into said bed is sufficiently low, e.g. no higher than about 30.degree. C., such that the bed of tocopheryl succinate remains in a fluidized state during said contacting and said evaporating.